PREVALENCE OF DYSLIPIDEMIA AND ASSOCIATED FACTORS AMONG HYPERTENSIVE PATIENTS IN DONG THAP PROVINCE

Tong Duc Minh1, Le Minh Phong2, Ngo Van Thuyen3
1 Vietnam Military Medical University
2 Military Hospital 175
3 Sa Dec General Hospital – Dong Thap

Main Article Content

Abstract

Objective: To determine the prevalence of dyslipidemia and associated factors among hypertensive patients in Dong Thap Province. Subjects and Methods: A cross-sectional descriptive study with analytical components was conducted on 1,200 hypertensive patients in Dong Thap Province from June 2022 to December 2024. Results: The prevalence of dyslipidemia among hypertensive patients was 89.50%. The proportions of elevated total cholesterol, elevated triglycerides, elevated LDL-C, and reduced HDL-C were 75.25%, 87.0%, 30.83%, and 17.67%, respectively. Dyslipidemia was more common in males (OR = 1.71; p = 0.003). Patients with an educational level of primary school or below had a 3.71-fold higher risk of dyslipidemia compared with those with secondary school education or higher (p < 0.001). Physically inactive patients had a 2.45-fold higher risk of dyslipidemia compared with physically active individuals (p < 0.001). Individuals who frequently consumed salt-rich foods (≥ 5 days/week) had a 2.31-fold higher risk of dyslipidemia compared with those who consumed such foods less frequently (< 5 days/week) (p < 0.001). Participants with BMI ≥ 23 had a 4.63-fold higher risk of dyslipidemia compared with those with BMI < 23 (p = 0.001). Non-adherent patients had a 3.07-fold higher risk of dyslipidemia compared with treatment-adherent patients. Conclusion: Dyslipidemia is highly prevalent among hypertensive patients in Dong Thap Province, particularly hypertriglyceridemia and elevated total cholesterol. Dyslipidemia was more common among males, physically inactive individuals, those who frequently consumed salt-rich foods, overweight and obese individuals (BMI ≥ 23), and patients with poor treatment adherence.

Article Details

References

1. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). European Heart Journal. 2024;45(38):3912–4018. https://doi.org/10.1093/eurheartj/ehae178
2. Tassew WC, Woldie SS, Ferede YA, Zeleke AM, Nigussie A. Dyslipidemia and associated factors among hypertensive patients in Ethiopia: a systematic review and meta-analysis. BMC Cardiovascular Disorders. 2025;25(1):367. https://doi.org/10.1186/s12872-025-04808-3
3. Nguyễn Văn Tuấn, Hoàng Thị Cúc. Nghiên cứu rối loạn lipid máu ở người cao tuổi tăng huyết áp. Tạp chí Y học Việt Nam. 2022;508(1). DOI: 10.51298/vmj.v508i1.1533.
4. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). The Journal of the American Medical Association. 2001;285(19):2486–97. DOI: 10.1001/jama.285.19.2486
5. Nguyễn Hoàng Phi, Huỳnh Kim Phượng, Huỳnh Trung Cang. Nghiên cứu tình hình rối loạn lipid máu và một số yếu tố liên quan ở bệnh nhân tăng huyết áp nguyên phát tại Bệnh viện Trường Đại học Y Dược Cần Thơ năm 2022-2023. Tạp chí Y Dược học Cần Thơ. 2023(64):104-10. DOI: 10.58490/ctump.2023i64.1370.
6. Nguyễn Chí Thanh, Lê Thị Kim Hương, Lê Thị Kim Cương. Nghiên cứu rối loạn lipid máu trên bệnh nhân tăng huyết áp. Tạp chí Y học Cộng đồng. 2026;67(4):306-9. DOI: https://doi.org/10.52163/yhc.v67iCD4.4859.
7. Lê Ngọc Hải Vân, Nguyễn Hùng Trấn. Tình hình rối loạn lipid máu và một số yếu tố liên quan ở bệnh nhân tăng huyết áp nguyên phát tại Bệnh viện Đại học Võ Trường Toản. Tạp chí Y học Việt Nam. 2024;541(1). DOI: 10.51298/vmj.v541i1.10638
8. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000;106(4):453-458. DOI: 10.1172/JCI10762